Stock listing
B3:N1VS34 Novartis AG Ações
Brazilian listing (B3) of Novartis AG · home listing SIX Swiss:NOVN
Follow Novartis AG into a list and get an email when it puts out news.
Share price · BMFBOVESPA:N1VS34
93.42 BRL +2.34 (+2.6%)
Close on Nov 16, 2026
- Day range
- 91.08 – 93.69 BRLNov 16, 2026
- Volume
- 49 sharesNov 16, 2026
- Market cap
- 1.78T BRLAt the close on Nov 16, 2026 · price × 19.01B shares outstanding
- 52-week range
- 67.64 – 93.69 BRLLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- 24,795 BRLMedian day 47 shares · 5 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:NOVN · Home | 134.26 CHF | -1.50 (-1.1%) | 374,101 | 134.98 | 135.28 | 134.14 | 135.76 | Delayed 15+ min · 12:44 PM GMT+1, Nov 17, 2026 |
| NYSE:NVS | $160.20 USD | -0.30 (-0.2%) | 1,630,384 | $162.36 | $163.28 | $159.94 | $160.50 | Close on Nov 16, 2026 |
| OTC:NVSEF | $159.26 USD | -2.855 (-1.8%) | 403 | $165.52 | $165.52 | $159.26 | $162.12 | Close on Nov 16, 2026 |
| Frankfurt:NOTA | €145.00 EUR | +2.00 (+1.4%) | — | €145.00 | €145.00 | €145.00 | €143.00 | Close on Nov 16, 2026 |
| B3:N1VS34 | 93.42 BRL | +2.34 (+2.6%) | 49 | 92.85 | 93.69 | 91.08 | 91.08 | Close on Nov 16, 2026 |
| TSX:NVS | $32.32 CAD | +0.31 (+1.0%) | 421 | $32.55 | $32.55 | $32.32 | $32.01 | Close on Nov 16, 2026 |
| LSE:0K9E | $161.15 USD | +0.85 (+0.5%) | 993 | $160.99 | $163.99 | $160.99 | $160.30 | Close on Nov 16, 2026 |
| Stuttgart:NOT | €145.60 EUR | +0.12 (+0.1%) | — | €145.28 | €148.02 | €145.28 | €145.48 | Close on Nov 16, 2026 |
| Munich:NOT | €145.90 EUR | +0.96 (+0.7%) | — | €145.94 | €145.94 | €145.90 | €144.94 | Close on Nov 16, 2026 |
| Dusseldorf:NOT | €145.52 EUR | +0.04 (0.0%) | — | €145.52 | €145.52 | €145.52 | €145.48 | Close on Nov 16, 2026 |
| Stuttgart:NOTA | €144.00 EUR | -2.00 (-1.4%) | 70 | €146.00 | €147.00 | €143.00 | €146.00 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · BMFBOVESPA:N1VS34 · BRL, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 89.90 | -1.00 | -1.1% | 88.56 | 89.90 | 88.20 | 159 | |
| 90.90 | +0.63 | +0.7% | 90.28 | 90.90 | 89.28 | 347 | |
| 90.27 | +2.13 | +2.4% | 89.19 | 90.27 | 89.19 | 195 | |
| 88.14 | -0.15 | -0.2% | 88.50 | 88.56 | 87.57 | 925 | |
| 88.29 | +1.30 | +1.5% | 87.20 | 88.29 | 87.20 | 1,947 | |
| 86.99 | +2.99 | +3.6% | 84.85 | 86.99 | 84.85 | 2,115 | |
| 84.00 | -0.08 | -0.1% | 84.32 | 84.32 | 84.00 | 18 | |
| 84.08 | +0.96 | +1.2% | 83.12 | 84.08 | 82.88 | 1,139 | |
| 83.12 | +7.52 | +9.9% | 83.45 | 83.45 | 82.64 | 318 | |
| 75.60 | -3.20 | -4.1% | 79.04 | 79.04 | 75.20 | 343 | |
| 78.80 | +1.60 | +2.1% | 75.65 | 78.96 | 75.65 | 586 | |
| 77.20 | -0.16 | -0.2% | 77.20 | 77.20 | 77.20 | 4 | |
| 77.36 | +1.20 | +1.6% | 76.20 | 77.36 | 76.20 | 2,022 | |
| 76.16 | -0.77 | -1.0% | 76.48 | 76.64 | 76.16 | 2,005 | |
| 76.93 | 0.00 | 0.0% | 76.93 | 76.93 | 76.93 | 0 | |
| 76.93 | +2.59 | +3.5% | 76.93 | 76.93 | 76.93 | 12 | |
| 74.34 | -5.74 | -7.2% | 80.09 | 80.09 | 74.13 | 113 | |
| 80.08 | +7.98 | +11.1% | 72.10 | 80.08 | 72.10 | 8 | |
| 72.10 | 0.00 | 0.0% | 72.10 | 72.10 | 72.10 | 0 | |
| 72.10 | +0.28 | +0.4% | 72.10 | 72.10 | 72.10 | 64 | |
| 71.82 | -0.28 | -0.4% | 70.65 | 71.82 | 70.65 | 189 | |
| 72.10 | +1.61 | +2.3% | 71.21 | 72.31 | 71.21 | 81 | |
| 70.49 | -0.21 | -0.3% | 70.49 | 70.49 | 70.49 | 47 | |
| 70.70 | -2.73 | -3.7% | 74.11 | 74.11 | 69.93 | 41 | |
| 73.43 | -0.49 | -0.7% | 73.43 | 73.43 | 73.43 | 2 | |
| 73.92 | -0.64 | -0.9% | 73.77 | 73.99 | 73.77 | 43 | |
| 74.56 | -1.68 | -2.2% | 77.01 | 77.01 | 73.92 | 298 | |
| 76.24 | -0.72 | -0.9% | 77.73 | 77.73 | 75.60 | 51 | |
| 76.96 | +1.36 | +1.8% | 76.32 | 76.96 | 76.16 | 159 | |
| 75.60 | +1.26 | +1.7% | 74.97 | 75.60 | 74.97 | 16 | |
| 74.34 | +0.56 | +0.8% | 74.52 | 74.76 | 74.20 | 281 | |
| 73.78 | +1.19 | +1.6% | 72.94 | 73.99 | 72.94 | 181 | |
| 72.59 | +0.14 | +0.2% | 73.18 | 73.18 | 72.10 | 17 | |
| 72.45 | -0.35 | -0.5% | 73.01 | 73.01 | 72.24 | 209 | |
| 72.80 | +0.14 | +0.2% | 71.20 | 72.80 | 71.20 | 634 | |
| 72.66 | +1.03 | +1.4% | 72.94 | 72.94 | 72.66 | 75 | |
| 71.63 | 0.00 | 0.0% | 71.63 | 71.63 | 71.63 | 7 | |
| 71.63 | -0.05 | -0.1% | 71.68 | 71.68 | 71.05 | 7 | |
| 71.68 | +1.26 | +1.8% | 72.00 | 73.15 | 71.68 | 472 | |
| 70.42 | -0.58 | -0.8% | 70.42 | 70.42 | 70.42 | 9 | |
| 71.00 | +0.51 | +0.7% | 71.40 | 71.40 | 71.00 | 105 | |
| 70.49 | +0.40 | +0.6% | 70.80 | 71.19 | 70.30 | 241 | |
| 70.09 | -11.91 | -14.5% | 72.10 | 72.10 | 69.99 | 1,993 | |
| 82.00 | 0.00 | 0.0% | 82.00 | 82.00 | 82.00 | 0 | |
| 82.00 | -0.88 | -1.1% | 82.00 | 82.00 | 82.00 | 7 | |
| 82.88 | -0.95 | -1.1% | 82.71 | 83.84 | 82.71 | 32 | |
| 83.83 | +0.83 | +1.0% | 83.83 | 83.83 | 83.83 | 2 | |
| 83.00 | +3.88 | +4.9% | 81.00 | 84.00 | 81.00 | 759 | |
| 79.12 | -0.96 | -1.2% | 79.20 | 79.20 | 79.12 | 2 | |
| 80.08 | -0.24 | -0.3% | 80.99 | 80.99 | 79.92 | 33 | |
| 80.32 | -1.44 | -1.8% | 80.32 | 80.32 | 80.32 | 1 | |
| 81.76 | -0.32 | -0.4% | 81.76 | 81.76 | 81.76 | 1 | |
| 82.08 | +6.20 | +8.2% | 81.41 | 82.25 | 81.41 | 20 | |
| 75.88 | -2.52 | -3.2% | 80.88 | 80.88 | 75.88 | 9 | |
| 78.40 | 0.00 | 0.0% | 78.40 | 78.40 | 78.40 | 0 | |
| 78.40 | 0.00 | 0.0% | 78.40 | 78.40 | 78.40 | 0 | |
| 78.40 | -1.60 | -2.0% | 78.40 | 78.40 | 78.40 | 1 | |
| 80.00 | +1.04 | +1.3% | 80.00 | 80.00 | 80.00 | 1 | |
| 78.96 | +0.32 | +0.4% | 78.96 | 78.96 | 78.96 | 1 |
- Ticker
- B3:N1VS34
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- B3
- Currency
- BRL
What changed lately
Latest news release · Nov 17, 2026
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Latest earnings call · Oct 27, 2026
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 91 slides
Calls
Replays
Novartis (SIX Swiss: NOVN) Q3 2026 Earnings Call
Tue, Oct 27, 2026 · 7:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q2 2026 Earnings Call
Tue, Jul 21, 2026 · 8:00 AM ET
Watch TranscriptNovartis (SIX Swiss: NOVN) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Oct 27, 2026
Closed 84.08 (+1.2%) on Oct 27, 2026
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Oct 23, 2026
Closed 75.60 (-4.1%) on Oct 23, 2026
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
Oct 21, 2026
Closed 77.20 (-0.2%) on Oct 21, 2026
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
Oct 7, 2026
Closed 72.10 (+2.3%) on Oct 7, 2026
CAS ประกาศความร่วมมือกับ Novartis เพื่อขับเคลื่อนระบบข้อมูลด้านปฏิกิริยาเคมีที่พร้อมรองรับ AI
Sep 29, 2026
Closed 76.24 (-0.9%) on Sep 29, 2026
Issued by another party
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Sep 18, 2026
Closed 72.80 (+0.2%) on Sep 18, 2026
Sironax Announces Option Exercise and Asset Purchase
Sep 16, 2026
Closed 71.63 (0.0%) on Sep 16, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 91 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 46 slides · Oct 23, 2026
Q2 2026 Earnings Presentation
Earnings · 87 slides · Jul 21, 2026
Q1 2026 Earnings Presentation
Earnings · 85 slides · Apr 28, 2026
Novartis AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 84 in the last 12 months · 117 in all · newest Nov 17, 2026 · oldest 2025
- Calls
- 26 calls with a replay · 26 with a transcript · latest Oct 27, 2026
- Decks
- 186 decks · latest Oct 27, 2026
Where Novartis AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:NOVN · Home listing | SIX Swiss | Switzerland | CHF |
| NYSE:NVS | NYSE | United States | USD |
| Xetra:NOT | Xetra | Germany | EUR |
| gettex:NOT | gettex | Germany | EUR |
| OTC:NVSEF | OTC | United States | USD |
| Tradegate:NOT | Tradegate | Germany | EUR |
| Milan:1NOVN | Milan | Italy | EUR |
| BCBA:NVS | BCBA | Argentina | ARS |
| LSIN:0QLR | LSIN | United Kingdom | CHF |
| gettex:NOTA | gettex | Germany | EUR |
| LS Exchange:904278 | LS Exchange | Germany | EUR |
| SIX Swiss:NOVNEE | SIX Swiss | Switzerland | CHF |
| BX Swiss:NOT | BX Swiss | Switzerland | CHF |
| Frankfurt:NOT | Frankfurt | Germany | EUR |
| Frankfurt:NOTA | Frankfurt | Germany | EUR |
| VIE:NOVN | Vienna | Austria | EUR |
| B3:N1VS34 · This page | B3 | Brazil | BRL |
| Tradegate:NOTA | Tradegate | Germany | EUR |
| TSX:NVS | TSX | Canada | CAD |
| Lang & Schwarz:904278 | Lang & Schwarz | Germany | EUR |
| Aquis:NOVNZ | Aquis | United Kingdom | CHF |
| Cboe Canada:NOVN | Cboe Canada | Canada | CAD |
| LSE:0K9E | LSE | United Kingdom | USD |
| Cboe Canada:NVS | Cboe Canada | Canada | CAD |
| Stuttgart:NOT | Stuttgart | Germany | EUR |
| BCBA:NVSD | BCBA | Argentina | USD |
| Munich:NOT | Munich | Germany | EUR |
| LS Exchange:907122 | LS Exchange | Germany | EUR |
| BMV:NVSN | BMV | Mexico | MXN |
| BCBA:NVSC | BCBA | Argentina | USD |
| BMV:NOVNN | BMV | Mexico | MXN |
| Hamburg:NOT | Hamburg | Germany | EUR |
| BOATS:NVS | BOATS | United States | USD |
| Dusseldorf:NOT | Dusseldorf | Germany | EUR |
| BCBA:NVSB | BCBA | Argentina | ARS |
| Stuttgart:NOTA | Stuttgart | Germany | EUR |
| Dusseldorf:NOTA | Dusseldorf | Germany | EUR |
| Hanover:NOT | Hanover | Germany | EUR |
| Frankfurt:NOT1 | Frankfurt | Germany | EUR |
| Turquoise:NOVNZ | Turquoise | United Kingdom | CHF |
| BIVA:NOVNN | BIVA | Mexico | MXN |
| Lang & Schwarz:907122 | Lang & Schwarz | Germany | EUR |
| Munich:NOTA | Munich | Germany | EUR |
| Frankfurt:NOT0 | Frankfurt | Germany | EUR |
| Hamburg:NOTA | Hamburg | Germany | EUR |
| BCBA:NVS.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Novartis AG.